Literature DB >> 3965404

Monoclonal antibodies to leukotoxin of Actinobacillus actinomycetemcomitans.

J M DiRienzo, C C Tsai, B J Shenker, N S Taichman, E T Lally.   

Abstract

Hybridoma cell lines which produce monoclonal antibodies to a leukotoxin from Actinobacillus actinomycetemcomitans were prepared. The monoclonal antibodies were selected for their ability to neutralize the cytotoxic activity of the leukotoxin and recognize the toxin on nitrocellulose blots. The antibodies belonged to either the immunoglobulin G1 (IgG1) or IgG2 subclass and differed in their ability to bind to the leukotoxin on nitrocellulose blots. However, only slight differences in neutralization titers were observed. Use of the monoclonal antibodies revealed that polymyxin B-extracted or osmotic shock-released leukotoxin could be separated into several high-molecular-weight polypeptides by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Immunoblot analysis with the monoclonal antibodies also demonstrated that the leukotoxin was present in eight oral strains of A. actinomycetemcomitans that had been previously classified by a biological assay as leukotoxic. The availability of these monoclonal antibodies should facilitate and expand studies concerning the role of the leukotoxin in the pathogenicity of A. actinomycetemcomitans.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965404      PMCID: PMC261455          DOI: 10.1128/iai.47.1.31-36.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Actinobacillus actinomycetemcomitans in human periodontal disease. Association, serology, leukotoxicity, and treatment.

Authors:  J Slots; J J Zambon; B G Rosling; H S Reynolds; L A Christersson; R J Genco
Journal:  J Periodontal Res       Date:  1982-09       Impact factor: 4.419

2.  Principles, problems, and strategies in the use of antigenic mixtures for the enzyme-linked immunosorbent assay.

Authors:  G E Kenny; C L Dunsmoor
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

3.  Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock.

Authors:  A Donohue-Rolfe; G T Keusch
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

4.  The adsorptive characteristics of proteins for polystyrene and their significance in solid-phase imunoassays.

Authors:  L A Cantarero; J E Butler; J W Osborne
Journal:  Anal Biochem       Date:  1980-07-01       Impact factor: 3.365

5.  Chemical mutagenesis at the phosphoribosyltransferase locus in cultured human lymphoblasts.

Authors:  K Sato; R S Slesinski; J W Littlefield
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

6.  Bacteriology of severe periodontitis in young adult humans.

Authors:  W E Moore; L V Holdeman; R M Smibert; D E Hash; J A Burmeister; R R Ranney
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

7.  Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli.

Authors:  D J Evans; D G Evans; S L Gorbach
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

8.  Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B.

Authors:  C C Tsai; B J Shenker; J M DiRienzo; D Malamud; N S Taichman
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

9.  Cellular location of heat-labile enterotoxin in Escherichia coli.

Authors:  T R Hirst; L L Randall; S J Hardy
Journal:  J Bacteriol       Date:  1984-02       Impact factor: 3.490

10.  Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency.

Authors:  J Slack; G P Der-Balian; M Nahm; J M Davie
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

View more
  12 in total

1.  Intra-oral colonization of macaque monkeys by Actinobacillus actinomycetemcomitans.

Authors:  D Beighton; N S Taichman; D L Simpson; J M Dirienzo; N W Johnson
Journal:  Oral Microbiol Immunol       Date:  1989-03

2.  Nuclease-sensitive binding of an Actinobacillus actinomycetemcomitans leukotoxin to the bacterial cell surface.

Authors:  H Ohta; K Kato; S Kokeguchi; H Hara; K Fukui; Y Murayama
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

3.  Differential regulation of the leukotoxin operon in highly leukotoxic and minimally leukotoxic strains of Actinobacillus actinomycetemcomitans.

Authors:  M Hritz; E Fisher; D R Demuth
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Effects of cations and osmotic protectants on cytolytic activity of Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  M Iwase; E T Lally; P Berthold; H M Korchak; N S Taichman
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Immunosuppressive properties of Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  G Rabie; E T Lally; B J Shenker
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

6.  Generation of a recombinant Aggregatibacter actinomycetemcomitans RTX toxin in Escherichia coli.

Authors:  Nataliya Balashova; Alexander Giannakakis; Angela C Brown; Evan Koufos; Roland Benz; Tsutomu Arakawa; Hsin-Yao Tang; Edward T Lally
Journal:  Gene       Date:  2018-06-04       Impact factor: 3.688

7.  Aggregatibacter actinomycetemcomitans leukotoxin causes activation of lymphocyte function-associated antigen 1.

Authors:  Patrik Nygren; Nataliya Balashova; Angela C Brown; Irene Kieba; Anuradha Dhingra; Kathleen Boesze-Battaglia; Edward T Lally
Journal:  Cell Microbiol       Date:  2018-11-28       Impact factor: 3.715

8.  Association of Actinobacillus actinomycetemcomitans leukotoxin with nucleic acids on the bacterial cell surface.

Authors:  H Ohta; H Hara; K Fukui; H Kurihara; Y Murayama; K Kato
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Membrane association and destabilization by Aggregatibacter actinomycetemcomitans leukotoxin requires changes in secondary structures.

Authors:  M J Walters; A C Brown; T C Edrington; S Baranwal; Y Du; E T Lally; K Boesze-Battaglia
Journal:  Mol Oral Microbiol       Date:  2013-05-16       Impact factor: 3.563

10.  Killing of human myelomonocytic leukemia and lymphocytic cell lines by Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  D L Simpson; P Berthold; N S Taichman
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.